W 193/06 OSR — Hikma Pharmaceuticals Plc
|To||Hikma Pharmaceuticals Plc|
5 Appold Street
London, EC2A 2HA
|DFSA Firm Reference No.||F000276|
THE DFSA HEREBY GIVES NOTICE THAT:
The Rules specified in the table herein do not apply to the above mentioned Person in the form appearing in the Rulebook but instead apply to that Person in the modified form prescribed in that table below.
This notice is issued by the DFSA under Article 25 of the Regulatory Law 2004.
Effective date: This notice comes into effect on 30 August 2006 and expires on 31 December 2006 or the date on which any Rule specified herein is amended, which ever is the earlier.
The Rules listed in the left hand column of the table below are modified as shown in the right hand column of the table. In this table, underlining indicates new text and striking through indicates deleted text.
The version of Rules to which this notice relates is (b) OSR_Apps1_3_VER5_06-06.
|OSR Appendix 2.1.16||
The modifications in respect of the Rules specified above remain in effect for the duration of the period set out above on condition that:
The provisions in this notice are to be construed in accordance with GEN section 6.2 as if these provisions are provisions of the Rulebook.
Defined terms are identified in this notice by the capitalisation of the initial letter of a word or of each word in a phrase and are defined in the Glossary (GLO). Unless the context otherwise requires, where capitalisation of the initial letter is not used, an expression has its natural meaning.
This notice was issued by:
|Name :||David Knott|
|Position :||Chief Executive Officer|
|Date :||30 August 2006|